Prednisolone Sodium Phosphate Solution
FDA Label NDC 0121-4759

38 label sections · Submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma for the product Prednisolone Sodium Phosphate (NDC 0121-4759). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, 1. allergic states, 2. dermatologic diseases, 3. edematous states, 4. endocrine disorders, 5. gastrointestinal diseases, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.